Britta Wahren

Britta Wahren

Professor Emeritus/Emerita
E-postadress: britta.wahren@ki.se
Besöksadress: Solnavägen 9, C9, 17165 Solna
Postadress: C1 Mikrobiologi, tumör- och cellbiologi, C1 MTC Chiodi, 171 77 Stockholm

Forskningsbeskrivning

  • Utvalda publikationer:Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.Latanova AA, Petkov S, Kilpelainen A, Jansons J, Latyshev OE, Kuzmenko YV, et alSci Rep 2018 May
  • 8(1):8078HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.Hinkula J, Petkov S, Ljungberg K, Hallengärd D, Bråve A, Isaguliants M, et alHeliyon 2017 Jun
  • 3(6):e00339Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.Bauer A, Podola L, Mann P, Missanga M, Haule A, Sudi L, et alJ. Virol. 2017 09
  • 91(18):Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses.Stenler S, Lundin KE, Hansen L, Petkov S, Mozafari N, Isaguliants M, et alHum Vaccin Immunother 2017 12
  • 13(12):2849-2858Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers.Joachim A, Munseri PJ, Nilsson C, Bakari M, Aboud S, Lyamuya EF, et alAIDS Res. Hum. Retroviruses 2017 08
  • 33(8):880-888Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission.Klein N, Palma P, Luzuriaga K, Pahwa S, Nastouli E, Gibb DM, et alLancet Infect Dis 2015 Sep
  • 15(9):1108-1114HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial.Nilsson C, Hejdeman B, Godoy-Ramirez K, Tecleab T, Scarlatti G, Bråve A, et alPLoS ONE 2015
  • 10(6):e0131748Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults.Joachim A, Nilsson C, Aboud S, Bakari M, Lyamuya EF, Robb ML, et alPLoS ONE 2015
  • 10(4):e0118486Immunotherapy with an HIV-DNA Vaccine in Children and Adults.Palma P, Gudmundsdotter L, Finocchi A, Eriksson LE, Mora N, Santilli V, et alVaccines (Basel) 2014 Jul
  • 2(3):563-80Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees.Nilsson C, Godoy-Ramirez K, Hejdeman B, Bråve A, Gudmundsdotter L, Hallengärd D, et alAIDS Res. Hum. Retroviruses 2014 Mar
  • 30(3):299-311

Artiklar

Alla övriga publikationer

Anställningar

  • Professor Emeritus/Emerita, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2024-2026
  • Professor Emeritus/Emerita, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2020-2023

Nyheter från KI

Kalenderhändelser från KI